LayerBio
Pre-clinicalOcuRing™ is novel bioerodible sustained-release technology for use with any standard intraocular lens (IOL) in cataract surgery.
Founded
2016
Focus
Drug Delivery
About
OcuRing™ is novel bioerodible sustained-release technology for use with any standard intraocular lens (IOL) in cataract surgery.
Funding History
2Total raised: $15M
Series A$12MUndisclosedMar 15, 2022
Seed$3MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2016
LocationLexington, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile